← Eichor
Study identifier: NCT05800665 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Condition: Advanced Prostate Cancer · Metastatic Prostate Cancer  ·  Sponsor: Genentech, Inc.

PhasePhase 1
Planned participants210
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary activity of RO7656594 in participants with advanced or metastatic prostate cancer. It will also identify recommended doses and regimens for RO7656594 for subsequent studies.

This description comes directly from the study's public registry record.

Talk to the study team

GO44537 https://forpatients.roche.com/ No attachments to email below.  ·  888-662-6728 (U.S. Only)  ·  global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (26)

HonorHealthScottsdale, Arizona, United StatesRecruiting
Yale Cancer CenterNew Haven, Connecticut, United StatesRecruiting
Sarah Cannon Research Institute @ Florida CancerOrlando, Florida, United StatesRecruiting
University of Illinois Hospital & Health Sciences SystemChicago, Illinois, United StatesRecruiting
SCRI Oncology PartnersNashville, Texas, United StatesRecruiting
St Vincent's Hospital SydneyDarlinghurst, New South Wales, AustraliaRecruiting
Macquarie University HospitalNew South Wales, New South Wales, AustraliaRecruiting
Monash Health Monash Medical CentreClayton, Victoria, AustraliaRecruiting
Austin HospitalHeidelberg, Victoria, AustraliaRecruiting
British Columbia Cancer AgencyVancouver, British Columbia, CanadaRecruiting
Princess Margaret HospitalToronto, Ontario, CanadaRecruiting
Gustave RoussyVillejuif, Val-de-Marne, FranceRecruiting

+ 14 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05800665